Neuropathic Pain Due to Diabetes Type I or Type II
Showing 26 - 50 of >10,000
Type 1 Diabetes Trial in Uppsala (Gamma-Aminobutyric Acid (GABA), Alprazolam)
Recruiting
- Type 1 Diabetes Mellitus
- Gamma-Aminobutyric Acid (GABA)
- Alprazolam
-
Uppsala, SwedenUppsala University Hospital
Sep 20, 2021
Type II Diabetes Trial in Seoul (CKD-379 I, CKD-379 II, D759+D745+D150)
Recruiting
- Type II Diabetes Mellitus
- CKD-379 I
- +2 more
-
Seoul, Jongno-gu, Korea, Republic ofSeoul National University Hospital
Jul 6, 2022
Baby Detect : Genomic Newborn Screening
Recruiting
- Congenital Adrenal Hyperplasia
- +126 more
-
Liege, Wallonia, BelgiumCRMN, Hôpital La Citadelle
Jan 24, 2023
Low Back Pain, Modic Changes Type I or II Seen on MRI Trial in Oslo (Amoxicillin (Amoksicillintrihydrat), Placebo)
Completed
- Low Back Pain
- Modic Changes Type I or II Seen on MRI
- Amoxicillin (Amoksicillintrihydrat)
- Placebo
-
Oslo, NorwayOslo University Hospital Ullevål
Sep 21, 2021
Diabetes Trial in L'Hospitalet de Llobregat, Valladolid (Bosentan, Placebo)
Recruiting
- Diabetes Mellitus
- Bosentan
- Placebo
-
L'Hospitalet de Llobregat, Barcelona, Spain
- +1 more
Apr 20, 2021
Physical Activity Levels in Type II Diabetes and/or COVID-19
Recruiting
- Covid19
- Diabetes Mellitus, Type 2
- COVID-19 group (Group I)
- Type II Diabetes Mellitus and COVID-19 group (Group II)
-
İzmir, TurkeyKadirhan Ozdemir
Feb 9, 2021
Diabetic Foot Ulcer Trial in Arezzo (debridement, Offloading, Advanced dressing)
Recruiting
- Diabetic Foot Ulcer
- debridement
- +3 more
-
Arezzo, ItalySan Donato Hospital
May 20, 2022
Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney
Recruiting
- Rare Disorders
- +309 more
-
Sioux Falls, South Dakota
- +1 more
Jun 20, 2022
Palliative Care, Diabetes, Type 2, Diabetes, Type 1 Trial in Israel, Italy, Switzerland (Continuous Glucose Monitoring, Standard
Active, not recruiting
- Palliative Care
- +8 more
- Continuous Glucose Monitoring
- Standard Care
-
Ramat Gan, Israel
- +5 more
Jul 20, 2021
Diabetic Peripheral Neuropathy Trial in Tainan (laser acupuncture, sham laser acupuncture)
Recruiting
- Diabetic Peripheral Neuropathy
- laser acupuncture
- sham laser acupuncture
-
Tainan, TaiwanTainan Municipal An Nan Hospital-China Medical University
Jun 25, 2023
Neuropathy, Diabetic, Pain, Neuropathic, Gait Disorder, Sensorimotor Trial in Ankara (Gait analysis, Balance Assessment)
Completed
- Neuropathy, Diabetic
- +2 more
- Gait analysis
- Balance Assessment
-
Ankara, Turkey
- +2 more
Feb 4, 2022
Type II Diabetes Trial in Seoul (CKD-393 formulation I, CKD-393 formulation II, D501, D759, H053)
Completed
- Type II Diabetes
- CKD-393 formulation I
- +2 more
-
Seoul, Seodaemun-gu,, Korea, Republic ofSeverance Hospital
Jul 29, 2021
Diabetes, Type 1 Trial in Charlottesville (Allogenic Islet Cell Transplantation)
Recruiting
- Diabetes Mellitus, Type 1
- Allogenic Islet Cell Transplantation
-
Charlottesville, VirginiaUniversity of Virginia
Jul 29, 2020
Fatty Liver, Nonalcoholic Trial (SGLT2 inhibitor)
Not yet recruiting
- Fatty Liver, Nonalcoholic
- SGLT2 inhibitor
- (no location specified)
Oct 31, 2023
Diabetic Neuropathy Peripheral Trial in Baltimore (Niagen, Placebo)
Suspended
- Diabetic Neuropathy Peripheral
- Niagen
- Placebo
-
Baltimore, MarylandUniversity of Maryland
Mar 24, 2022
Peripheral Arterial Disease (PAD), Diabetes (DM), Diabetes, Type 1 Trial in Worldwide (REX-001, Placebo)
Terminated
- Peripheral Arterial Disease (PAD)
- +5 more
- REX-001
- Placebo
-
Ostrava, Czechia
- +14 more
May 5, 2021
Diabetic Neuropathy, Painful Trial in Adiyaman (randomized controlled study)
Completed
- Diabetic Neuropathy, Painful
- randomized controlled study
-
Adıyaman, TurkeyReva Gundogan
Jun 17, 2023
Type 2 Diabetes Trial in Worldwide (Ertugliflozin 5 mg, Ertugliflozin 15 mg, Placebo)
Recruiting
- Type 2 Diabetes Mellitus
- Ertugliflozin 5 mg
- +4 more
-
Birmingham, Alabama
- +99 more
Nov 25, 2022
Type 1 Diabetes Trial in Worldwide (LY900014, Insulin Lispro, Insulin Glargine)
Type1diabetes Trial in Cairo (Detection of RAGE gene polymorphism (rs1800625))
Completed
- Type1diabetes
- Detection of RAGE gene polymorphism (rs1800625)
-
Cairo, EgyptNational Institute of Diabetes and Endocrinology's
May 23, 2023
Role of the Liver in Glucose Homeostasis Using Metabolic Imaging
Completed
- Type 1 Diabetes
- Bariatric Surgery Candidate
- Multiparametric, multinuclear MR (DMI/ 13C-MRS/ GlycoCEST/GlycoNOE)
-
Bern, SwitzerlandInselspital, Bern University Hospital and University Hospital of
Nov 14, 2022
Diabetes, Type 2 Trial in Worldwide (Canagliflozin 100 mg, Canagliflozin 300 mg, Placebo)
Recruiting
- Diabetes Mellitus, Type 2
- Canagliflozin 100 mg
- +2 more
-
Little Rock, Arkansas
- +121 more
Aug 18, 2022
IV Lidocaine Infusion for Neuropathic Pain
Withdrawn
- Neuropathic Pain
- +2 more
-
Detroit, MichiganHenry Ford Health Systems
Feb 7, 2023
Diabetic Foot Ulcer, Temporomandibular Disorder, Swallowing Disorder Trial in Sanliurfa (observation)
Completed
- Diabetic Foot Ulcer
- +2 more
- observation
-
Sanliurfa, Haliliye, TurkeyFatih Enzin
Sep 27, 2023
Dental Implant Trial (Type I Dental implant placement., Type II Dental implant placement., Type III/IV dental implant
Not yet recruiting
- Dental Implant
- Type I Dental implant placement.
- +2 more
- (no location specified)
Aug 4, 2023